$7.28
-0.02[-0.27%]
At close: Apr 26
$7.28
0[0.00%]
After Hours: 4:20PM EDT
Pulmonx
(NASDAQ:LUNG)Pulmonx Stock (NASDAQ:LUNG), Analyst Ratings, Price Targets, Predictions
Pulmonx Corp has a consensus price target of $17.4, established from looking at the 38 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, Citigroup, and Wells Fargo on April 3, 2024, February 23, 2024, and February 23, 2024. With an average price target of $16 between Piper Sandler, Citigroup, and Wells Fargo, there's an implied 119.78% upside for Pulmonx Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Citigroup
Wells Fargo
Stifel
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Pulmonx
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2024 | LUNG | Buy Now | Pulmonx | $7.28 | 133.52% | Piper Sandler | Jason Bednar | $17 → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | LUNG | Buy Now | Pulmonx | $7.28 | 133.52% | Citigroup | Joanne Wuensch | $16 → $17 | Maintains | Buy | Get Alert |
| 02/23/2024 | LUNG | Buy Now | Pulmonx | $7.28 | 92.31% | Wells Fargo | Larry Biegelsen | $16 → $14 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/22/2024 | LUNG | Buy Now | Pulmonx | $7.28 | 133.52% | Stifel | Rick Wise | $15 → $17 | Maintains | Buy | Get Alert |
| 02/22/2024 | LUNG | Buy Now | Pulmonx | $7.28 | 133.52% | Piper Sandler | Jason Bednar | $13 → $17 | Maintains | Overweight | Get Alert |
| 02/22/2024 | LUNG | Buy Now | Pulmonx | $7.28 | 119.78% | Wells Fargo | Larry Biegelsen | $15 → $16 | Maintains | Overweight | Get Alert |
| 10/31/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 78.57% | Piper Sandler | Jason Bednar | $17 → $13 | Maintains | Overweight | Get Alert |
| 10/31/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 64.84% | Canaccord Genuity | William Plovanic | $20 → $12 | Maintains | Buy | Get Alert |
| 09/05/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 147.25% | Craig-Hallum | Alexander Nowak | → $18 | Initiates | → Buy | Get Alert |
| 08/03/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 133.52% | Piper Sandler | Jason Bednar | $15 → $17 | Maintains | Overweight | Get Alert |
| 07/11/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 119.78% | Citigroup | Joanne Wuensch | $14 → $16 | Maintains | Buy | Get Alert |
| 05/03/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 92.31% | Citigroup | Joanne Wuensch | $13 → $14 | Maintains | Buy | Get Alert |
| 05/03/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 106.04% | Piper Sandler | Jason Bednar | $13 → $15 | Maintains | Overweight | Get Alert |
| 05/03/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 92.31% | Morgan Stanley | Cecilia Furlong | $11 → $14 | Maintains | Equal-Weight | Get Alert |
| 04/03/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 78.57% | Citigroup | Joanne Wuensch | $12 → $13 | Maintains | Buy | Get Alert |
| 02/27/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 106.04% | Wells Fargo | Larry Biegelsen | $10 → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/24/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 64.84% | Citigroup | Joanne Wuensch | $10 → $12 | Maintains | Buy | Get Alert |
| 02/23/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 174.73% | Canaccord Genuity | William Plovanic | $18 → $20 | Maintains | Buy | Get Alert |
| 02/23/2023 | LUNG | Buy Now | Pulmonx | $7.28 | 51.1% | Morgan Stanley | Cecilia Furlong | $9.5 → $11 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Pulmonx (LUNG)?
The latest price target for Pulmonx (NASDAQ: LUNG) was reported by Piper Sandler on April 3, 2024. The analyst firm set a price target for $17.00 expecting LUNG to rise to within 12 months (a possible 133.52% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pulmonx (LUNG)?
The latest analyst rating for Pulmonx (NASDAQ: LUNG) was provided by Piper Sandler, and Pulmonx reiterated their overweight rating.
When was the last upgrade for Pulmonx (LUNG)?
The last upgrade for Pulmonx Corp happened on February 27, 2023 when Wells Fargo raised their price target to $15. Wells Fargo previously had an equal-weight for Pulmonx Corp.
When was the last downgrade for Pulmonx (LUNG)?
The last downgrade for Pulmonx Corp happened on February 23, 2024 when Wells Fargo changed their price target from $16 to $14 for Pulmonx Corp.
When is the next analyst rating going to be posted or updated for Pulmonx (LUNG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pulmonx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pulmonx was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
Is the Analyst Rating Pulmonx (LUNG) correct?
While ratings are subjective and will change, the latest Pulmonx (LUNG) rating was a reiterated with a price target of $17.00 to $17.00. The current price Pulmonx (LUNG) is trading at is $7.28, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.